SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
62 hedge funds and large institutions have $223M invested in scPharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+3
Holders Change %
+5.08%
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
15
Increased
24
Reduced
14
Closed
12
Calls
$990K
Puts
$591K
Net Calls
+$399K
Net Calls Change
+$790K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$29.9M |
| 2 |
CAC
Cowen and Company
New York
|
+$25.5M |
| 3 |
JFG
Jefferies Financial Group
New York
|
+$11.9M |
| 4 |
Morgan Stanley
New York
|
+$9.24M |
| 5 |
Millennium Management
New York
|
+$7.51M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$15.4M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
-$13.9M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$13.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.83M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$4.3M |
